News

NIH-led effort – including ISB – launches Big Data portal for Alzheimer’s drug discovery

The National Institutes of Health announced the launch of a new Alzheimer’s Big Data portal, which includes the first wave of data for use by the research community. This portal is the result of the Accelerating Medicines Partnership (AMP) program, which focuses on facilitating collaboration among government agencies, academia and industry in order to translate research more quickly to therapies.

The launch of the AMP Alzeheimers Disease Knowledge Portal is the first major release of the project, to which a consortium of teams contribute data and analysis: Eric Schadt, Ph.D., Icahn School of Medicine at Mount Sinai, New York; Philip De Jager, M.D., Ph.D., Eli and Edythe L. Broad Institute of MIT and Harvard, Boston; Todd Golde, M.D., Ph.D., University of Florida, Gainesville; and Alan Levey, M.D., Ph.D., Emory University, Atlanta. Researchers from Rush University, Chicago; Mayo Clinic, Jacksonville, Fla.; Institute for Systems Biology, Seattle; the University of California, Los Angeles and a number of other academic centers are also participating. ISB’s Price Lab is participating in this project through a collaboration with the University of Florida.

Ben Heavner, a research scientist in the Price Lab, is leading the bioinformatics work, which involves translating raw data into a uniform format and then uploading to the data portal. “This is a huge step for open science,” Ben said. “This portal offers access to thousands of data sets pre-publication so that all researchers have the opportunity to make the discoveries that will lead to better therapeutics .”

Read more about the NIH’s $45M in grants to support Alzheimer’s research.

Related Articles

  • Clinical Trial Explores the Effects of Health Coaching on Cognitive Function in Patients with Early-Stage Alzheimer’s

    Institute for Systems Biology (ISB) is among several organizations conducting a clinical trial testing how health coaching affects the cognitive function of patients with early-stage Alzheimer’s disease and analyzing longitudinal, multi-omic data to explore transitions in cognitive function over time.

  • How Scientific Wellness will drive the future of health

    ‘Hyper Wellbeing’ is a summit to foster an emerging consumer technology industry. Consumer data-driven health, wellness and lifestyle optimization plus disease risk reduction. It represents a power shift towards the consumer and the future of mobile, wearables, health and wellness. Nathan Price presented at the Wellness as a Service World Summit, which took place on 14th November 2016 at the Computer History Museum (1401 N. Shoreline Blvd. Mountain View, CA…

  • “Genomics, Big Data, Informatics and the Future of Medicine”: Nathan Price at the 2015 TLC

    Nathan Price gave a talk titled “Genomics, Big Data, Informatics and the Future of Medicine” at the Personalized Lifestyle Medicine Institute‘s (PLMI) 2015 Thought Leaders Consortium (TLC), held in Chicago, October 24-25. The theme of the 2015 TLC was the Future of Genomics in Healthcare: from Personalized Cancer Therapy to Wellness.

Show More Articles